论文部分内容阅读
目的探讨健康服务团队干预对2型糖尿病患者病情预后及影响。方法选择2010年1月—2013年1月门诊诊断明确的2型糖尿病患者280例,随机分为对照组和干预组各140例。对照组给予常规治疗,干预组在对照组基础上,重点给予健康教育、营养治疗、体育锻炼、电子档案,每人每年不少于4次或以上的空腹血糖检测和随访,并制定详细的个体化药物治疗方案。结果两组干预前空腹血糖、餐后2小时血糖、并发症发生率,比较差异无统计学意义(均P>0.05),干预后对照组空腹血糖、餐后2小时血糖[(9.1±1.8)(10.4±2.5)mmol/l]与干预组[(6.2±1.2)(8.1±1.8)mmol/l]比较,均有统计学意义(P<0.05)。干预后对照组并发症发生率占41.43%,死亡2例。干预组并发症发生率占22.14%,无死亡病列,两组比较,差异均有统计学意义(P<0.05)。结论健康干预对2型糖尿病患者,可有效控制患者血糖、减少或延缓并发症发生、降低病死率,对2型糖尿病的二、三级预防有很好的效果,值得推广。
Objective To investigate the prognosis and impact of health service team intervention on type 2 diabetes mellitus patients. Methods 280 patients with type 2 diabetes mellitus diagnosed from January 2010 to January 2013 were randomly divided into control group and intervention group (140 cases each). The control group was given routine treatment. In the control group, the intervention group gave priority to health education, nutrition treatment, physical exercise and electronic file. Fasting blood glucose test and follow-up of not less than 4 times per person per year or above were conducted and a detailed individual Drug treatment programs. Results There was no significant difference in fasting blood glucose, 2-hour postprandial blood glucose and postoperative complication between the two groups (all P> 0.05). After the intervention, fasting blood glucose, 2-hour postprandial blood glucose [(9.1 ± 1.8) (10.4 ± 2.5) mmol / l] compared with those in the intervention group [(6.2 ± 1.2) (8.1 ± 1.8) mmol / l], both of which were statistically significant (P <0.05). After intervention, the incidence of complications in the control group accounted for 41.43%, 2 died. The incidence of complications in the intervention group accounted for 22.14%, no death pathology, the two groups, the difference was statistically significant (P <0.05). Conclusion The intervention of health intervention can effectively control the blood sugar of patients with type 2 diabetes mellitus, reduce or delay the occurrence of complications, reduce the mortality and have good effects on the prevention of type 2 diabetes secondary and tertiary and should be promoted.